📰
Politics
Dermatology Biotech Bambusa Dips 6.3% After $168.9 Million IPO
📅30 October 2026 at 15:37
📰Bloomberg
👁️1 views
Share:
📰
Article Preview
Bambusa Therapeutics Inc. shares slipped 6.3% in its trading debut after the early-stage biotech focused on dermatology and autoimmune diseases raised $168.9 million in a US initial public offering.
🎧
Listen to Preview
Audio version available
🔇
Audio Reader
Not supported in this browser
Want the full story?
Click below to load the complete article with full details, analysis, and context.
Share this story
Share:
Source: This article was originally published by Bloomberg. All rights reserved to the original publisher.
Comments
Loading comments...
Related Stories
Stay Updated
Get the latest Nigerian news delivered to your inbox.